Cargando...
Access to benznidazole for Chagas disease in the United States—Cautious optimism?
Drugs for neglected tropical diseases (NTD) are being excessively priced in the United States. Benznidazole, the first-line drug for Chagas disease, may become approved by the Food and Drug Administration (FDA) and manufactured by a private company in the US, thus placing it at risk of similar prici...
Guardado en:
| Publicado en: | PLoS Negl Trop Dis |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Public Library of Science
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5598921/ https://ncbi.nlm.nih.gov/pubmed/28910299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0005794 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|